ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

PYM Phytopharm

58.00
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Phytopharm LSE:PYM London Ordinary Share GB00BCLY7L40 ORD 50P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 58.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

IXICO plc Exercise of Share Options (0640B)

02/10/2015 11:18am

UK Regulatory


Phytopharm (LSE:PYM)
Historical Stock Chart


From Jun 2019 to Jun 2024

Click Here for more Phytopharm Charts.

TIDMIXI

RNS Number : 0640B

IXICO plc

02 October 2015

2 October 2015

IXICO plc

(the 'Company')

Exercise of Share Options

IXICO plc ("IXICO" or the "Company")

Additional Listing

IXICO (AIM: IXI) announces that 142,581 new ordinary shares of 50 pence each in IXICO plc (the "New Ordinary Shares") have been issued and allotted pursuant to the exercise of options under the IXICO Technologies Limited Unapproved Share Option Scheme (the "Scheme"). Under the terms of the Scheme the new shares issued and allotted in IXICO Technologies Limited are subject to a put and call arrangement resulting in the New Ordinary Shares being issued and allotted.

Application has been made to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM. Admission is expected to be effective on 8 October 2015 and, when issued, the New Ordinary Shares will rank pari passu in all respects with the Company's existing ordinary shares.

Following the admission to trading of the New Ordinary Shares, IXICO will have 15,201,563 ordinary shares of 50 pence each in issue.

Enquiries:

IXICO plc

Derek Hill, CEO

Susan Lowther, CFO

Charles Spicer, VP Corporate Development

+44 20 3763 7499

Peel Hunt LLP (Nominated Adviser and Broker)

James Steel

Oliver Jackson

+44 20 7418 8900+44 20 7418 8900

Daniel Stewart & Company (Joint Broker)

Mark Treharne

David Hart

+44 207 776 6550+44 207 776 6550

This information is provided by RNS

The company news service from the London Stock Exchange

END

LISLLFLIISLFIIE

(END) Dow Jones Newswires

October 02, 2015 06:18 ET (10:18 GMT)

1 Year Phytopharm Chart

1 Year Phytopharm Chart

1 Month Phytopharm Chart

1 Month Phytopharm Chart